Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Koçak-19 COVID-19 Vaccine
NCT04838080Phase 1Unknown
- Sponsor
- Koçak Farma
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Inactivated COVID-19 vaccine (Kocak Farma) in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Koçak Farma. Primary endpoint: Adverse Events. Status: unknown.
02
Drugs
Inactivated COVID-19 vaccine (Kocak Farma)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04838080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838080.